Journal Publications, 2004
The NIH Library provides information about online journal access.
December
Immunity
T Cell receptor recognition motifs govern immune escape patterns in acute SIV Infection.
Price DA, West SM, Betts MR, Ruff LE, Brenchley JM, Ambrozak DR, Edghill-Smith Y, Kuroda MJ, Bogdan D, Kunstman K, Letvin NL, Franchini G, Wolinsky SM, Koup RA, Douek DC.
Immunity. 2004. Dec;21(6):793-803.
Immunity
Thymic output and HIV infection: on the right TREC.
Douek D.
Immunity. 2004. Dec;21(6):744-5.
Journal of Experimental Medicine
T cell cross-reactivity and conformational changes during TCR engagement.
Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, Dorrell L, Douek DC, van der Merwe PA, Jones EY, McMichael AJ.
J Exp Med. 2004. Dec 6;200(11):1455-66.
Immunology Reviews
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses.
Barouch DH, Letvin NL, Seder RA.
Immunol Rev. 2004. Dec;202:266-74.
Virology
Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins.
Grundner C, Pancera M, Kang JM, Koch M, Sodroski J, Wyatt R.
Virology. 2004. Dec 5;330(1):233-48.
Expert Review of Vaccines
Vaccine cell substrates 2004.
Sheets R, Petricciani J.
Expert Rev Vaccines. 2004. Dec;3(6):633-8.
November
Journal of Virology
Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production.
Huang Y, Yang ZY, Kong WP, Nabel GJ.
J Virol. 2004 Nov;78(22):12557-65.
Journal of Virology
Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies.
Ganesh L, Leung K, Lore K, Levin R, Panet A, Schwartz O, Koup RA, Nabel GJ.
J Virol. 2004 Nov;78(21):11980-7.
Virus Research
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium-RSV 2003.
Schmidt AC, Johnson TR, Openshaw PJ, Braciale TJ, Falsey AR, Anderson LJ, Wertz GW, Groothuis JR, Prince GA, Melero JA, Graham BS.
Virus Res. 2004 Nov;106(1):1-13.
Journal of Virology
Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS.
J Virol. 2004 Nov;78(22):12471-9.
Journal of Biological Chemistry
Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition.
Laugel B, Boulter JM, Lisssin N, Vuidepot A, Li Y, Gostick E, Crotty LA, Douek DC, Hemelaar J, Price DA, Jakobsen BK, Sewell AK.
J Biol Chem. 2004 Nov 4; [Epub ahead of print]
Journal of Immunology
Vaccination in humans generates broad T cell cytokine responses.
De Rosa SC, Lu FX, Yu J, Perfetto SP, Falloon J, Moser S, Evans TG, Koup R, Miller CJ, Roederer M.
J Immunol. 2004 Nov 1;173(9):5372-80.
Virology
Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins.
Grundner C, Pancera M, Kang JM, Koch M, Sodroski J, Wyatt R.
Virology. 2004 Dec 5;330(1):233-48.
October
Journal of Virology
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.
Hashimoto K, Graham BS, Geraci MW, FitzGerald GA, Egan K, Zhou W, Goleniewska K, O'Neal JF, Morrow JD, Durbin RK, Wright PF, Collins RD, Suzutani T, Peebles RS Jr.
J Virol. 2004 Oct;78(19):10303-9.
Nature Medicine
Memory may not need reminding.
Seder RA, Sacks DL.
Nat Med. 2004 Oct;10(10):1045-7.
Blood
Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis.
Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW.
Blood. 2004 Oct 1;104(7):2007-9
Journal of Virology
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.
Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, Wyatt R, Kwong PD.
J Virol. 2004 Oct;78(19):10724-37
September
Journal of Immunology
Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection.
Rutigliano JA, Graham BS.
J Immunol. 2004 Sep 1;173(5):3408-17.
Journal of Infectious Diseases
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL.
J Infect Dis. 2004 Sep 1;190(5):903-7
Tissue Antigens
HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting.
Paris R, Bejrachandra S, Karnasuta C, Chandanayingyong D, Kunachiwa W, Leetrakool N, Prakalapakorn S, Thongcharoen P, Nittayaphan S, Pitisuttithum P, Suriyanon V, Gurunathan S, McNeil JG, Brown AE, Birx DL, de Souza M.
Tissue Antigens. 2004 Sep;64(3):251-6.
Journal of Experimental Medicine
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract.
Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC.
J Exp Med. 2004 Sep 20;200(6):749-59
American Journal of Pathology
Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling.
Baumgarth N, Szubin R, Dolganov GM, Watnik MR, Greenspan D, Da Costa M, Palefsky JM, Jordan R, Roederer M, Greenspan JS.
Am J Pathol. 2004 Sep;165(3):707-18.
August
Nature Reviews Immunology
Seventeen-colour flow cytometry: unravelling the immune system.
Perfetto SP, Chattopadhyay PK, Roederer M.
Nat Rev Immunol. 2004 Aug;4(8):648-55.
Journal of Virology
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
Johnson TR, Varga SM, Braciale TJ, Graham BS
J Virol. 2004 Aug;78(16):8753-60.
July
Journal of Antimicrobial Chemotherapy
Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
Budge PJ, Graham BS.
J Antimicrob Chemother. 2004 Aug;54(2):299-302.
Journal of Infectious Diseases
Safety and Immunogenicity of an HIV Subtype B and E Prime-Boost Vaccine Combination in HIV-Negative Thai Adults.
Nitayaphan S, Pitisuttithum P, Karnasuta C, Eamsila C, De Souza M, Morgan P, Polonis V, Benenson M, VanCott T, Ratto-Kim S, Kim J, Thapinta D, Garner R, Bussaratid V, Singharaj P, El Habib R, Gurunathan S, Heyward W, Birx D, McNeil J, Brown AE; Thai AIDS Vaccine Evaluation Group.
J Infect Dis. 2004 Aug 15;190(4):702-6.
Journal of Immunology
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.
J Immunol. 2004 Aug 1;173(3):2126-33.
June
Clinical Infectious Diseases
Modified vaccinia ankara: potential as an alternative smallpox vaccine.
McCurdy LH, Larkin BD, Martin JE, Graham BS.
Clin Infect Dis. 2004 38(12):1749-53.
Journal of Virology
pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.
Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ.
J Virol. 2004 Jun;78(11):5642-50.
Journal of Virology
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.
Johnson TR, Teng MN, Collins PL, Graham BS.
J Virol. 2004 Jun;78(11):6024-32.
Blood
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.
Crawford MP, Yan SX, Ortega SB, Mehta RS, Hewitt RE, Price DA, Stastny P, Douek DC, Koup RA, Racke MK, Karandikar NJ.
Blood. 2004 Jun 1;103(11):4222-31
Blood
Unusual Immunophenotype of CD8+ T-cells in Familial Hemophagocytic Lymphohistiocytosis.
Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW.
Blood. 2004 Jun 17
May
Journal of Immunology
A Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J.
J Immunol. 2004 May 172(10):6290-7.
America Journal of Respiratory Critical Care Medicine
Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5.
Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, Zhou W, Suzutani T, Jones PW, Goleniewska K, O'Neal JF, Peebles RS Jr.
Am J Respir Crit Care Med. 2004 Aug 1;170(3):306-12.
Nature Medicine
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
Pantaleo G, Koup RA.
Nat Med. 2004 Aug;10(8):806-10.
Journal of Immunology
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.
J Immunol. 2004 Aug 1;173(3):2126-33.
AIDS Research and Human Retroviruses
Macaque Dendritic Cells Infected with SIV-Recombinant Canarypox ex Vivo Induce SIV-Specific Immune Responses in Vivo.
Villamide-Herrera L, Ignatius R, Eller MA, Wilkinson K, Griffin C, Mehlhop E, Jones J, Han SY, Lewis MG, Parrish S, Vancott TC, Lifson JD, Schlesinger S, Mascola JR, Pope M.
AIDS Res Hum Retroviruses. 2004 Aug;20(8):871-84.
Journal of Infectious Diseases
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
Nitayaphan S, Pitisuttithum P, Karnasuta C, Eamsila C, de Souza M, Morgan P, Polonis V, Benenson M, VanCott T, Ratto-Kim S, Kim J, Thapinta D, Garner R, Bussaratid V, Singharaj P, el-Habib R, Gurunathan S, Heyward W, Birx D, McNeil J, Brown AE; Thai AIDS Vaccine Evaluation Group.
J Infect Dis. 2004 Aug 15;190(4):702-6.
Journal of Antimicrobial Chemotherapy
Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
Budge PJ, Graham BS.
J Antimicrob ChemotherInfect Dis. 2004 Jul 14 [Epub ahead of print]
Journal of Infectious Diseases
Safety and Immunogenicity of an HIV Subtype B and E Prime-Boost Vaccine Combination in HIV-Negative Thai Adults.
Nitayaphan S, Pitisuttithum P, Karnasuta C, Eamsila C, De Souza M, Morgan P, Polonis V, Benenson M, VanCott T, Ratto-Kim S, Kim J, Thapinta D, Garner R, Bussaratid V, Singharaj P, El Habib R, Gurunathan S, Heyward W, Birx D, McNeil J, Brown AE; Thai AIDS Vaccine Evaluation Group.
J Infect Dis. 2004 Aug 15;190(4):702-6.
Journal of Immunology
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.
J Immunol. 2004 Aug 1;173(3):2126-33.
Clinical Infectious Diseases
Modified vaccinia ankara: potential as an alternative smallpox vaccine.
McCurdy LH, Larkin BD, Martin JE, Graham BS.
Clin Infect Dis. 2004 38(12):1749-53.
Journal of Virology
pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.
Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ.
J Virol. 2004 Jun;78(11):5642-50.
Journal of Virology
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.
Johnson TR, Teng MN, Collins PL, Graham BS.
J Virol. 2004 Jun;78(11):6024-32.
Blood
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.
Crawford MP, Yan SX, Ortega SB, Mehta RS, Hewitt RE, Price DA, Stastny P, Douek DC, Koup RA, Racke MK, Karandikar NJ.
Blood. 2004 Jun 1;103(11):4222-31
Blood
Unusual Immunophenotype of CD8+ T-cells in Familial Hemophagocytic Lymphohistiocytosis.
Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW.
Blood. 2004 Jun 17
Journal of Immunology
A Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J.
J Immunol. 2004 May 172(10):6290-7.
American Journal of Respiratory and Critical Care Medicine
Respiratory Syncytial Virus in Allergic Lung Inflammation Increases Muc5ac and gob-5.
A Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, Zhou W, Suzutani T, Jones PW, Goleniewska K, O'Neal JF, Peebles Jr RS.
Am J Respir Crit Care Med. 2004 May 6 (Epub ahead of print).
Journal of Virology
RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.
Budge PJ, Li Y, Beeler JA, Graham BS.
J Virol. 2004 May;78(10):5015-22.
Journal of Immunology
The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.
Betts MR, Price DA, Brenchley JM, Lore K, Guenaga FJ, Smed-Sorensen A, Ambrozak DR, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA.
J Immunol. 2004 May 15;172(10):6407-17.
Journal of Immunology
Adult human liver contains CD8(pos) T cells with naive phenotype, but is not a site for conventional alphabeta T cell development.
Golden-Mason L, Douek DC, Koup RA, Kelly J, Hegarty JE, O'Farrelly C.
J Immunol. 2004 May 15;172(10):5980-5.
Journal of Virology
Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120.
Brainard DM, Tharp WG, Granado E, Miller N, Trocha AK, Ren XH, Conrad B, Terwilliger EF, Wyatt R, Walker BD, Poznansky MC.
J Virol. 2004 May;78(10):5184-93.
Journal of Virology
Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination.
Zhang L, Ribeiro RM, Mascola JR, Lewis MG, Stiegler G, Katinger H, Perelson AS, Davenport MP.
J Virol. 2004 May;78(10):5520-2.
Journal of Virology
Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins.
Liao HX, Alam SM, Mascola JR, Robinson J, Ma B, Montefiori DC, Rhein M, Sutherland LL, Scearce R, Haynes BF.
J Virol. 2004 May;78(10):5270-8.
April
Nature
DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.
Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ.
Nature. 2004 Apr 1;428(6982):561-4.
Journal of Virology
Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope.
Yang ZY, Chakrabarti BK, Xu L, Welcher B, Kong WP, Leung K, Panet A, Mascola JR, Nabel GJ.
J Virol. 2004 Apr;78(8):4029-36.
Journal of Experimental Medicine
Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T Cells.
Wolint P, Betts MR, Koup RA, Oxenius A.
J Exp Med. 2004 Apr 5;199(7):925-36
Blood
Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase.
Fujiwara H, El Ouriaghli F, Grube M, Price DA, Rezvani K, Gostick E, Sconocchia G, Melenhorst J, Hensel N, Douek DC, Barrett AJ.
Blood. 2004 Apr 15;103(8):3076-83.
Current HIV/AIDS Reports
Current Advances in HIV Vaccines
D'Souza, MP, Allen M, Sheets R, Johnston MI
Current HIV/AIDS Reports 2004. April 1:18-24
March
Journal of Virology
The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope.
Gorny MK, Revesz K, Williams C, Volsky B, Louder MK, Anyangwe CA, Krachmarov C, Kayman SC, Pinter A, Nadas A, Nyambi PN, Mascola JR, Zolla-Pazner S.
J Virol. 2004 Mar 1;78(5):2394-2404
Journal of Virology
Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.
Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS.
J Virol. 2004 Mar;78(6):3014-3023.
Nature Immunology
HIV vaccine design and the neutralizing antibody problem.
Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT.
Nat Immunol. 2004 Mar;5(3):233-6. No abstract available.
February
Blood
High Prevalence of Autoreactive Neuroantigen-Specific CD8+ T Cells in Multiple Sclerosis Revealed by Novel Flow Cytometric Assay.
Crawford MP, Yan SX, Ortega S, Mehta RS, Hewitt RE, Price DA, Stastny P, Douek DC, Koup RA, Racke MK, Karandikar NJ.
Blood. 2004 Epub ahead of print
Journal of Immunology
HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4(+) memory T cells located within Langerhans cell-T cell clusters.
Sugaya M, Lore K, Koup RA, Douek DC, Blauvelt A.
J Immunol. 2004 Feb 15;172(4):2219-24.
Journal of Virology
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.
Brenchley JM, Hill BJ, Ambrozak DR, Price DA, Guenaga FJ, Casazza JP, Kuruppu J, Yazdani J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA.
J Virol. 2004 Feb;78(3):1160-8
Journal of Immunology
HLA class II polymorphisms determine responses to bacterial superantigens.
Llewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, Cohen J, Altmann DM.
J Immunol. 2004 Feb 1;172(3):1719-26.
Journal of AIDS
Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.
Safrit JT, Ruprecht R, Ferrantelli F, Xu W, Kitabwalla M, Van Rompay K, Marthas M, Haigwood N, Mascola JR, Luzuriaga K, Jones SA, Mathieson BJ, Newell ML; Ghent IAS Working Group on HIV in Women Children.
J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):169-77
Journal of Immunology
Ontogeny of gammadelta T cells in humans.
De Rosa SC, Andrus JP, Perfetto SP, Mantovani JJ, Herzenberg LA, Herzenberg LA, Roederer M.
J Immunol. 2004 Feb 1;172(3):1637-45
Nature Medicine
Genetic, cellular and immune approaches to disease therapy: past and future.
Nabel GJ
Nat Med. 2004 Feb;10(2): 135-41.
Proceedings of the National Academy of Sciences
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.
Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S, Zhang MY, Dimitrov DS, Hendrickson WA, Robinson J, Sodroski J, Wyatt R, Choe H, Farzan M, Kwong PD.
Proc Natl Acad Sci U S A.M 2004 Feb 23 [Epub ahead of print]
Structure
The 447-52D Antibody: Hitting HIV-1.
Kwong PD.
Structure. 2004 Feb;12(2):173-4.
January
EMBO Journal
A novel role for XIAP in copper homeostasis through regulation of MURR1.
Burstein E, Ganesh L, Dick RD, Van De Sluis B, Wilkinson JC, Klomp LW, Wijmenga C, Brewer GJ, Nabel GJ, Duckett CS
EMBO J. 23(1): 244-54.
Journal of Virology
Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol.
Cen S, Niu M, Saadatmand J, Guo F, Huang Y, Nabel GJ, Kleiman L.
J Virol. 2004 Jan; 78(2): 1042-9
Pediatric Infectious Disease Journal
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR, Graham BS.
Pediatr Infect Dis J. 2004 Jan; 23(1): S46-S57.
AIDS
T-cell dynamics during acute SIV infection.
Mattapallil JJ, Letvin NL, Roederer M.
AIDS. 2004 Jan 2;18(1):13-23.
back to top